BACKGROUND: The Homeobox B (HOXB) family promotes tumor progression, but the mechanism of its action in gastric cancer (GC) is unclear. We sought to identify the HOXB family members that are critical to the prognosis of GC patients. METHODS: The Oncomine, Gene Expression Profiling Interactive Analysis (GEPIA), cBioPortal, UALCAN, Kaplan-Meier plotter, and the GeneMANIA databases were used to analyze the messenger RNA (mRNA) expression levels, prognostic value, and gene-gene interaction network of the HOXB9 family members in GC. The expression of HOXB9 in GC and its relationship with various clinicopathological parameters and the prognosis of patients were verified by immunohistochemistry. RESULTS: The expression of HOXB3, HOXB5, HOXB6, HOXB7, HOXB9, and HOXB13 mRNA was significantly upregulated in GC. There was a significant correlation between the upregulation of HOXB3, HOXB5, and HOXB9 mRNA and a low overall survival (OS) rate. The high expression of HOXB7, HOXB9, and HOXB13 mRNA was closely correlated to tumor grade and stage. HOXB9 was the HOXB family member most closely related to the occurrence and development of GC. A further analysis showed that HOXB9 might be involved in deoxyribonucleic acid repair and division regulation. A validation study showed that the advanced cancer group had a higher level of HOXB9 expression than the early cancer group. The high expression of HOXB9 in gastric tissue plays an important role in the survival and prognosis of GC patients. CONCLUSIONS: HOXB family members have different degrees of abnormal expression in GC. High HOXB9 expression in GC tissues was significantly correlated with a worse prognosis. Thus, HOXB9 is a potential novel biomarker and therapeutic target for GC. 2021 Journal of Gastrointestinal Oncology. All rights reserved.
BACKGROUND: The Homeobox B (HOXB) family promotes tumor progression, but the mechanism of its action in gastric cancer (GC) is unclear. We sought to identify the HOXB family members that are critical to the prognosis of GC patients. METHODS: The Oncomine, Gene Expression Profiling Interactive Analysis (GEPIA), cBioPortal, UALCAN, Kaplan-Meier plotter, and the GeneMANIA databases were used to analyze the messenger RNA (mRNA) expression levels, prognostic value, and gene-gene interaction network of the HOXB9 family members in GC. The expression of HOXB9 in GC and its relationship with various clinicopathological parameters and the prognosis of patients were verified by immunohistochemistry. RESULTS: The expression of HOXB3, HOXB5, HOXB6, HOXB7, HOXB9, and HOXB13 mRNA was significantly upregulated in GC. There was a significant correlation between the upregulation of HOXB3, HOXB5, and HOXB9 mRNA and a low overall survival (OS) rate. The high expression of HOXB7, HOXB9, and HOXB13 mRNA was closely correlated to tumor grade and stage. HOXB9 was the HOXB family member most closely related to the occurrence and development of GC. A further analysis showed that HOXB9 might be involved in deoxyribonucleic acid repair and division regulation. A validation study showed that the advanced cancer group had a higher level of HOXB9 expression than the early cancer group. The high expression of HOXB9 in gastric tissue plays an important role in the survival and prognosis of GC patients. CONCLUSIONS: HOXB family members have different degrees of abnormal expression in GC. High HOXB9 expression in GC tissues was significantly correlated with a worse prognosis. Thus, HOXB9 is a potential novel biomarker and therapeutic target for GC. 2021 Journal of Gastrointestinal Oncology. All rights reserved.
Entities:
Keywords:
Gastric cancer (GC); Homeobox B family (HOXB family); Homeobox B9 (HOXB9); prognosis biomarker; therapeutic target
Authors: Naokazu Chiba; Valentine Comaills; Bunsyo Shiotani; Fumiyuki Takahashi; Toshiyuki Shimada; Ken Tajima; Daniel Winokur; Tetsu Hayashida; Henning Willers; Elena Brachtel; Maria D M Vivanco; Daniel A Haber; Lee Zou; Shyamala Maheswaran Journal: Proc Natl Acad Sci U S A Date: 2011-09-19 Impact factor: 11.205
Authors: Stephan Winnik; Mei Klinkert; Haymo Kurz; Christoph Zoeller; Jennifer Heinke; Yaxu Wu; Christoph Bode; Cam Patterson; Martin Moser Journal: Cardiovasc Res Date: 2009-04-29 Impact factor: 10.787
Authors: Frank Ulrich Weiss; Ines J Marques; Joost M Woltering; Danielle H Vlecken; Ali Aghdassi; Lars Ivo Partecke; Claus-Dieter Heidecke; Markus M Lerch; Christoph P Bagowski Journal: Gastroenterology Date: 2009-09-10 Impact factor: 22.682
Authors: Juan Cui; Yunbo Chen; Wen-Chi Chou; Liankun Sun; Li Chen; Jian Suo; Zhaohui Ni; Ming Zhang; Xiaoxia Kong; Lisabeth L Hoffman; Jinsong Kang; Yingying Su; Victor Olman; Darryl Johnson; Daniel W Tench; I Jonathan Amster; Ron Orlando; David Puett; Fan Li; Ying Xu Journal: Nucleic Acids Res Date: 2010-10-21 Impact factor: 16.971